126: 1393407 Shear N, Spielberg S, Grant D, et al
Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, et al
bulk amount available upon request Storage: Long Term: -80C Short Term: 4C Application: Detection of protein-glutathione addicts on Western blot under non-reducing conditions
Running it alongside a concurrent multi-peptide protocol would create a scheduling overlap that conflicts with its design as a standalone reset
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment